Cargando…
Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
The advent of antiretroviral therapy (ART) has seen a dramatic decrease in the morbidity and mortality of individuals infected with human immunodeficiency virus (HIV). However, ART is not curative and HIV persists in treated individuals within a pool of infected CD4(+) memory T cells. The targeting...
Autores principales: | Boyer, Zoe, Palmer, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232919/ https://www.ncbi.nlm.nih.gov/pubmed/30459753 http://dx.doi.org/10.3389/fimmu.2018.02339 |
Ejemplares similares
-
Unequal distribution of genetically-intact HIV-1 proviruses in cells expressing the immune checkpoint markers PD-1 and/or CTLA-4
por: Fisher, Katie, et al.
Publicado: (2023) -
Agonistic and antagonistic targeting of immune checkpoint molecules differentially regulate osteoclastogenesis
por: Brom, Victoria C., et al.
Publicado: (2023) -
Immune Checkpoint Molecules in Reproductive Immunology
por: Miko, Eva, et al.
Publicado: (2019) -
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018) -
The CD83 Molecule – An Important Immune Checkpoint
por: Grosche, Linda, et al.
Publicado: (2020)